Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Virtual Advanced Course on KRAS Targeting in NSCLC 2021

ESMO-Virtual-Advanced-Course-KRAS-Targeting-NSCLC-2021-1000x250
Start date
13 Oct 2021
End date
14 Oct 2021
Location
Virtual, CEST Time

Learning objectives

  • Understanding the function and biology of KRAS in normal and malignant cells
  • Gaining insights in the spectrum of KRAS molecular aberrations, platforms and strategies for molecular testing
  • In depth discussion of emerging therapeutic strategies and clinical research in KRAS mutated NSCLC
  • Presenting novel data on biomarkers of benefit, mechanisms of resistance and combinatorial therapeutic strategies of KRAS G12C inhibition and beyond

Download the programme

Accreditation

The programme of this event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to  ESMO-MORA Recertification Process & Requirements.

Co-Chairs

  • Marina C. Garassino, United States
  • Natasha Leighl, Canada

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.